$TEM news
The latest TEM stock news: headlines, filings, AI summaries and sentiment for $TEM, updated around the clock.
- Tempus AI Shares Rise Following Q3 Earnings Beat and Increased Revenue Guidance
- Midday Market Update: Oracle Slumps on Debt Plans While IDEXX and Tempus AI Surge on Earnings
- Tempus AI Projects 2026 Revenue Between $1.60B and $1.605B with Target Adjusted EBITDA of $65M
- Tempus AI Reports Q3 2026 Growth Driven by Oncology Volume and Data Licensing
- Tempus AI Reports 23% Revenue Growth and Narrows Net Loss in Third Quarter
- Tempus AI Exceeds Q3 Earnings Estimates and Raises FY26 Outlook
- Tempus AI, Inc. - 10-Q Filing
- Tempus AI, Inc. - 8-K Filing
- Key Corporate Earnings Scheduled for Monday Pre-Market Session
- Bristol Myers Squibb Reports 1% Increase in Legacy Revenue and 12% Growth in New Portfolio Sales
- Tempus AI Expands Cancer Therapy Collaboration with Moderna and Merck
- BTIG Downgrades Personalis Following Tempus Acquisition
- Tempus AI Chief Accounting Officer Sells $529,650 Worth of Stock
- Goldman Sachs Assigns $75 Target to Tempus AI, But Data Business Faces Renewal Risks
- Tempus AI Outlines Growth Strategy Fueled by Pricing Increases and Data Licensing Expansion
- Tempus AI Awarded $9.5M Grant to Develop Autonomous Heart Failure Agent
- Tempus AI Shares Surge After Morgan Stanley Raises Revenue Outlook
- Tempus AI shares rise following analyst upgrades
- Tempus AI Stock Rises After Cantor Fitzgerald Issues Overweight Rating
- Tempus AI Director Sells Shares Under Rule 10b5-1 Plan
- Cathie Wood's Ark Invest Adjusts Portfolio: Boosts NVDA, AVGO as AMD Leads Sales
- Ark Invest Adjusts Portfolio: Boosting Exposure to NVDA, AVGO While Reducing AMD
- Tempus AI's Acquisition of Personalis Gains Strategic Momentum Following Melanoma Trial Success
- Tempus AI CEO Sells $6.6 Million in Stock Before Significant Rally
- Tempus AI Executive Sells Shares to Cover Tax Obligations Amid Segment Growth
- Tempus AI Diagnostics Chief Sells Shares Amid Volatile Week
- Tempus AI CFO James William Rogers Sells Shares Amid Tax Withholding Requirements
- Tempus AI's Chief Accounting Officer Reports Insider Share Sale
- Tempus AI's Legal Chief Sells Shares Amid Stock Rally
- Tempus AI Director Sells Stock Before Significant Rally
- Tempus AI Surges Amid Merck and Moderna's Cancer Vaccine Trial Update
- Tempus AI Set to Report Q2 Earnings Amid Pending Acquisition
- Tempus AI CEO Sells $10.5 Million Worth of Shares Amid Ongoing Losses
- Tempus AI CEO Sells 250,000 Shares via Pre-Scheduled Plan
- Tempus AI, Inc. - 10-Q Filing
- Tempus AI, Inc. - 8-K Filing
- Cathie Wood Invests $8.7 Million in Tempus AI Amid Market Volatility
- MindWalk Unveils Biological Context Layer for AI Drug Discovery at AMD Event
- Tempus Acquires Personalis for $1.5 Billion in Bid to Control Cancer-Test Market
- Cathie Wood Invests $8.7 Million in Tempus AI Amid Market Volatility
- Tempus Acquires Personalis for $1.5 Billion to Expand Cancer Testing Capabilities
- Tempus Agrees to Acquire Cancer Test Maker Personalis for $1.5 Billion
- Tempus AI Acquires Cancer-Monitoring Firm Personalis for $1.5 Billion
- Tempus AI Acquires Personalis in $1.5 Billion Precision Oncology Deal
- Tempus AI, Inc. - 8-K Filing
- Tempus AI Acquires Personalis to Expand MRD Testing and Biopharma Capabilities
- Tempus AI Acquires Cancer-Monitoring Firm Personalis for $1.5 Billion
- Tempus AI Acquires Personalis in $1.5 Billion Deal to Expand Cancer Testing Capabilities
- Tempus AI, Inc. - 8-K Filing
- Tempus AI Launches Next-Gen Agentic Platform to Accelerate Oncology Research